Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at zanidatamab and standard treatment for bile duct and gallbladder cancer (HERIZON-BTC-302)

Overview

Cancer types:

Bile duct cancer, Biliary tree cancers, Gallbladder cancer, Secondary cancers

Status:

Open

Phase:

Phase 3

Details

This trial is looking at adding a drug called zanidatamab to for bile duct and gallbladder cancer.

It is for people whose cancer:

  • has spread into surrounding tissues and they can’t have surgery to remove it or it has spread elsewhere in the body

  • is

You pronounce zanidatamab as zan-i-dat-a-mab.

Recruitment start: 19 July 2024

Recruitment end: 1 December 2028

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr James J Harding

Supported by

Jazz Pharmaceuticals

Last reviewed: 20 Jan 2026

CRUK internal database number: 20041

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Find a Clinical Trial

Search our clinical trials database for all cancer trials and studies recruiting in the UK.

An icon of two speech bubbles, indicating a conversation.

Cancer Chat forum

Connect with other people affected by cancer and share your experiences.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.